Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInvestment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Shares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

MediWound (MDWD) Net Income towards Common Stockholders: 2011-2024

Historic Net Income towards Common Stockholders for MediWound (MDWD) over the last 14 years, with Dec 2024 value amounting to -$30.2 million.

  • MediWound's Net Income towards Common Stockholders fell 5493.33% to -$6.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$25.2 million, marking a year-over-year decrease of 185.12%. This contributed to the annual value of -$30.2 million for FY2024, which is 350.03% down from last year.
  • As of FY2024, MediWound's Net Income towards Common Stockholders stood at -$30.2 million, which was down 350.03% from -$6.7 million recorded in FY2023.
  • In the past 5 years, MediWound's Net Income towards Common Stockholders ranged from a high of $80,000 in FY2020 and a low of -$30.2 million during FY2024.
  • Its 3-year average for Net Income towards Common Stockholders is -$18.8 million, with a median of -$19.6 million in 2022.
  • As far as peak fluctuations go, MediWound's Net Income towards Common Stockholders slumped by 17,038.75% in 2021, and later spiked by 65.73% in 2023.
  • Yearly analysis of 5 years shows MediWound's Net Income towards Common Stockholders stood at $80,000 in 2020, then crashed by 17,038.75% to -$13.6 million in 2021, then plummeted by 44.63% to -$19.6 million in 2022, then spiked by 65.73% to -$6.7 million in 2023, then tumbled by 350.03% to -$30.2 million in 2024.